188 related articles for article (PubMed ID: 24086476)
21. Hepatic nitric oxide synthase 1 adaptor protein regulates glucose homeostasis and hepatic insulin sensitivity in obese mice depending on its PDZ binding domain.
Mu K; Sun Y; Zhao Y; Zhao T; Li Q; Zhang M; Li H; Zhang R; Hu C; Wang C; Jia W
EBioMedicine; 2019 Sep; 47():352-364. PubMed ID: 31473185
[TBL] [Abstract][Full Text] [Related]
22. Trefoil Factor 3 Deficiency Affects Liver Lipid Metabolism.
Bujak M; Bujak IT; Sobočanec S; Mihalj M; Novak S; Ćosić A; Levak MT; Kopačin V; Mihaljević B; Balog T; Drenjančević I; Loncar MB
Cell Physiol Biochem; 2018; 47(2):827-841. PubMed ID: 29807366
[TBL] [Abstract][Full Text] [Related]
23. Spexin alleviates insulin resistance and inhibits hepatic gluconeogenesis via the FoxO1/PGC-1α pathway in high-fat-diet-induced rats and insulin resistant cells.
Gu L; Ding X; Wang Y; Gu M; Zhang J; Yan S; Li N; Song Z; Yin J; Lu L; Peng Y
Int J Biol Sci; 2019; 15(13):2815-2829. PubMed ID: 31853220
[No Abstract] [Full Text] [Related]
24. NFIL3 is a negative regulator of hepatic gluconeogenesis.
Kang G; Han HS; Koo SH
Metabolism; 2017 Dec; 77():13-22. PubMed ID: 29132537
[TBL] [Abstract][Full Text] [Related]
25. The hepatic FOXQ1 transcription factor regulates glucose metabolism in mice.
Cui Y; Qiao A; Jiao T; Zhang H; Xue Y; Zou Y; Cui A; Fang F; Chang Y
Diabetologia; 2016 Oct; 59(10):2229-39. PubMed ID: 27421728
[TBL] [Abstract][Full Text] [Related]
26. Regulation of hepatic gluconeogenesis by nuclear factor Y transcription factor in mice.
Zhang Y; Guan Q; Liu Y; Zhang Y; Chen Y; Chen J; Liu Y; Su Z
J Biol Chem; 2018 May; 293(20):7894-7904. PubMed ID: 29530977
[TBL] [Abstract][Full Text] [Related]
27. Hepatic Activation of the FAM3C-HSF1-CaM Pathway Attenuates Hyperglycemia of Obese Diabetic Mice.
Chen Z; Ding L; Yang W; Wang J; Chen L; Chang Y; Geng B; Cui Q; Guan Y; Yang J
Diabetes; 2017 May; 66(5):1185-1197. PubMed ID: 28246289
[TBL] [Abstract][Full Text] [Related]
28. miR-696 plays a role in hepatic gluconeogenesis in ob/ob mice by targeting PGC-1α.
Fang Z; Li P; Jia W; Jiang T; Wang Z; Xiang Y
Int J Mol Med; 2016 Sep; 38(3):845-52. PubMed ID: 27432632
[TBL] [Abstract][Full Text] [Related]
29. Hepatic Gadd45β promotes hyperglycemia and glucose intolerance through DNA demethylation of PGC-1α.
Wu L; Jiao Y; Li Y; Jiang J; Zhao L; Li M; Li B; Yan Z; Chen X; Li X; Lu Y
J Exp Med; 2021 May; 218(5):. PubMed ID: 33688917
[TBL] [Abstract][Full Text] [Related]
30. Whole body overexpression of PGC-1alpha has opposite effects on hepatic and muscle insulin sensitivity.
Liang H; Balas B; Tantiwong P; Dube J; Goodpaster BH; O'Doherty RM; DeFronzo RA; Richardson A; Musi N; Ward WF
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E945-54. PubMed ID: 19208857
[TBL] [Abstract][Full Text] [Related]
31. Hepatic GALE Regulates Whole-Body Glucose Homeostasis by Modulating
Zhu Y; Zhao S; Deng Y; Gordillo R; Ghaben AL; Shao M; Zhang F; Xu P; Li Y; Cao H; Zagnitko O; Scott DA; Gupta RK; Xing C; Zhang BB; Lin HV; Scherer PE
Diabetes; 2017 Nov; 66(11):2789-2799. PubMed ID: 28877911
[TBL] [Abstract][Full Text] [Related]
32. Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.
Yan Y; Sha Y; Huang X; Yuan W; Wu F; Hong J; Fang S; Huang B; Hu C; Wang B; Zhang X
Obes Surg; 2019 Sep; 29(9):2912-2922. PubMed ID: 31079286
[TBL] [Abstract][Full Text] [Related]
33. Pck1 gene silencing in the liver improves glycemia control, insulin sensitivity, and dyslipidemia in db/db mice.
Gómez-Valadés AG; Méndez-Lucas A; Vidal-Alabró A; Blasco FX; Chillon M; Bartrons R; Bermúdez J; Perales JC
Diabetes; 2008 Aug; 57(8):2199-210. PubMed ID: 18443203
[TBL] [Abstract][Full Text] [Related]
34. TCF7L2 modulates glucose homeostasis by regulating CREB- and FoxO1-dependent transcriptional pathway in the liver.
Oh KJ; Park J; Kim SS; Oh H; Choi CS; Koo SH
PLoS Genet; 2012 Sep; 8(9):e1002986. PubMed ID: 23028378
[TBL] [Abstract][Full Text] [Related]
35. Oleanolic acid improves hepatic insulin resistance via antioxidant, hypolipidemic and anti-inflammatory effects.
Wang X; Liu R; Zhang W; Zhang X; Liao N; Wang Z; Li W; Qin X; Hai C
Mol Cell Endocrinol; 2013 Aug; 376(1-2):70-80. PubMed ID: 23791844
[TBL] [Abstract][Full Text] [Related]
36. Upregulation of lncRNA MEG3 promotes hepatic insulin resistance via increasing FoxO1 expression.
Zhu X; Wu YB; Zhou J; Kang DM
Biochem Biophys Res Commun; 2016 Jan; 469(2):319-25. PubMed ID: 26603935
[TBL] [Abstract][Full Text] [Related]
37. DAX-1 acts as a novel corepressor of orphan nuclear receptor HNF4alpha and negatively regulates gluconeogenic enzyme gene expression.
Nedumaran B; Hong S; Xie YB; Kim YH; Seo WY; Lee MW; Lee CH; Koo SH; Choi HS
J Biol Chem; 2009 Oct; 284(40):27511-23. PubMed ID: 19651776
[TBL] [Abstract][Full Text] [Related]
38. Bradykinin inhibits hepatic gluconeogenesis in obese mice.
Barros CC; Haro A; Russo FJ; Schadock I; Almeida SS; Reis FC; Moraes MR; Haidar A; Hirata AE; Mori M; Bacurau RF; Würtele M; Bader M; Pesquero JB; Araujo RC
Lab Invest; 2012 Oct; 92(10):1419-27. PubMed ID: 22868909
[TBL] [Abstract][Full Text] [Related]
39. A decrease in hepatic microRNA-9 expression impairs gluconeogenesis by targeting FOXO1 in obese mice.
Yan C; Chen J; Li M; Xuan W; Su D; You H; Huang Y; Chen N; Liang X
Diabetologia; 2016 Jul; 59(7):1524-1532. PubMed ID: 27003684
[TBL] [Abstract][Full Text] [Related]
40. Prostaglandin F
Wang Y; Yan S; Xiao B; Zuo S; Zhang Q; Chen G; Yu Y; Chen D; Liu Q; Liu Y; Shen Y; Yu Y
Diabetes; 2018 Sep; 67(9):1748-1760. PubMed ID: 29773555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
